Advanced search
Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 33, 2021 - Issue 6
Submit an article Journal homepage
711
Views
7
CrossRef citations to date
0
Altmetric
Articles

Acceptability and preferences for long-acting antiretroviral formulations among people with HIV infection

Dima Dandachia Division of Infectious Diseases, Department of Medicine, University of Missouri, Columbia, MO, USA;b Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USACorrespondence[email protected] [email protected]
View further author information
,
Bich N. Dangb Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA;c VA Center for Innovations in Quality, Effectiveness and Safety, Houston, TX, USA;d Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA;e School of Medicine, Baylor College of Medicine, Houston, TX, USAView further author information
,
Brandon Lucarie School of Medicine, Baylor College of Medicine, Houston, TX, USAView further author information
,
Susan Swindellsf Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USAView further author information
&
Thomas P. Giordanob Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA;c VA Center for Innovations in Quality, Effectiveness and Safety, Houston, TX, USA;d Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA;e School of Medicine, Baylor College of Medicine, Houston, TX, USAView further author information
Pages 801-809 | Received 23 Sep 2019, Accepted 30 Apr 2020, Published online: 14 May 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Séverine Carillon, Gabrièle Laborde-Balen, Maïmouna Diop, Karim Diop, Guillaume Breton, Bara Ndiaye & Bernard Taverne. (2023) Implementing long-acting injectable antiretroviral treatments in Senegal: issues, challenges and conditions for introducing them. Qualitative study with healthcare providers and patients. AIDS Care 0:0, pages 1-7.
Read now

Articles from other publishers (6)

Chloe Orkin, Shinichi Oka, Patrick Philibert, Cynthia Brinson, Ayesha Bassa, Denis Gusev, Olaf Degen, Juan González García, Enrique Bernal Morell, Darrell H S Tan, Ronald D'Amico, David Dorey, Sandy Griffith, Shanker Thiagarajah, Marty St Clair, Rodica Van Solingen-Ristea, Herta Crauwels, Susan L Ford, Parul Patel, Vasiliki Chounta, Simon Vanveggel, Amy Cutrell, Veerle Van Eygen, Kati Vandermeulen, David A Margolis, Kimberly Y Smith & William R Spreen. (2021) Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study. The Lancet HIV 8:4, pages e185-e196.
Crossref
Thumbi Ndung’u. (2021) Will Long-Acting Antiretroviral Therapy be a Game Changer Globally?. Med 2:2, pages 115-117.
Crossref
Kimberly K. Scarsi & Susan Swindells. (2021) The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?. Journal of the International Association of Providers of AIDS Care (JIAPAC) 20, pages 232595822110090.
Crossref
Karine DubéDanielle M. CampbellKelly E. PerryJohn T. KanazawaParya SaberiJohn A. SaucedaTonia PoteatDavid Evans. (2020) Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options. AIDS Research and Human Retroviruses 36:12, pages 1054-1058.
Crossref
Edgar T Overton, Gary Richmond, Giuliano Rizzardini, Hans Jaeger, Catherine Orrell, Firaya Nagimova, Fritz Bredeek, Miguel García Deltoro, Susan Swindells, Jaime Federico Andrade-Villanueva, Alexander Wong, Marie-Aude Khuong-Josses, Rodica Van Solingen-Ristea, Veerle van Eygen, Herta Crauwels, Susan Ford, Christine Talarico, Paul Benn, Yuanyuan Wang, Krischan J Hudson, Vasiliki Chounta, Amy Cutrell, Parul Patel, Mark Shaefer, David A Margolis, Kimberly Y Smith, Simon Vanveggel & William Spreen. (2020) Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. The Lancet 396:10267, pages 1994-2005.
Crossref
Deanna Kerrigan, Tahilin Sanchez Karver, Ohvia Muraleetharan, Virginia Savage, Jessie Mbwambo, Yeycy Donastorg, Samuel Likindikoki, Martha Perez, Hoisex Gomez, Andrea Mantsios, Miranda Murray, S. Wilson Beckham, Wendy Davis, Noya Galai & Clare Barrington. (2020) “A dream come true”: Perspectives on long-acting injectable antiretroviral therapy among female sex workers living with HIV from the Dominican Republic and Tanzania. PLOS ONE 15:6, pages e0234666.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.